The group's principle activity is to develop and commercializes superior biological factories (Bio-Factories) and innovative biomanufacturing processes for the manufacture of high value chemical and biological products. The group's technology includes model-driven research and development, simulation and publications. The group's solutions include SimPheny(TM), model collection, and collaborative science. The group operates from United States.
